Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Xiao, Jia ^a,b   Xing, Feiyue ^a   Huo, Jie ^a   Fung, Man Lung ^b   Liong, Emily C ^b   Ching, Yick Pang ^b   Xu, Aimin ^b   Chang, Raymond Chuen Chung ^b   So, Kwok Fai ^a,b   Tipoe, George L ^b  

^a JINAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; ARABINOSE; BETA CAROTENE; HERBACEOUS AGENT; LYCIUM BARBARUM POLYSACCHARIDE;

ADVERSE EFFECTS; ANIMAL; APOPTOSIS; AUTOPHAGY; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; FEMALE; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIVER; LIVER CELL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OXIDATIVE STRESS; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-OBESITY AGENTS; APOPTOSIS; ARABINOSE; AUTOPHAGY; BETA CAROTENE; CELL SURVIVAL; CELLS, CULTURED; DIET, HIGH-FAT; DRUGS, CHINESE HERBAL; FEMALE; HEPATOCYTES; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MAP KINASE SIGNALING SYSTEM; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY;

EID: 84904962594     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05587     Document Type: Article

References (44)

1. Browning, J. D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 40, 1387-1395 (2004). (Pubitemid 39657013)
2. Michelotti, G. A.,Machado, M. V.&Diehl, A. M. NAFLD, NASH and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 10, 656-665 (2013).
3. Yilmaz, Y. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment. Pharmacol. Ther. 36, 815-823 (2012).
4. Xiao, J., Guo, R., Fung, M. L., Liong, E. C.&Tipoe, G. L. Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. Hepatobiliary Pancreat. Dis. Int. 12, 125-135 (2013).
5. Vitaglione, P. et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology. 52, 1652-1661 (2010).
6. Xiao, J. et al. Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model. Eur. J. Nutr. 52, 179-191 (2013).
7. Xiao, J. et al. Garlic-Derived S-Allylmercaptocysteine Ameliorates Nonalcoholic Fatty Liver Disease in a Rat Model through Inhibition of Apoptosis and Enhancing Autophagy. Evid. Based Complement. Alternat. Med. 2013, 642920 (2013).
8. Xiao, J. et al. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Eur. J. Nutr. doi:10.1007/s00394-013-0516-8 (2013).
9. Cacciapuoti, F., Scognamiglio, A., Palumbo, R., Forte, R. & Cacciapuoti, F. Silymarin in non alcoholic fatty liver disease. World J. Hepatol. 5, 109-113 (2013).
10. Xin, P. et al. Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats. Food Chem. Toxicol. 52, 12-18 (2013).
11. Chang, R. C. & So, K. F. Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far? Cell. Mol. Neurobiol. 28, 643-652 (2008). (Pubitemid 351905068)
12. Zhang, M. et al. Effect of lycium barbarum polysaccharide on human hepatoma QGY7703 cells: inhibition of proliferation and induction of apoptosis. Life Sci. 76, 2115-2124 (2005). (Pubitemid 40249369)
13. Li, S. Y. et al. Lycium barbarum polysaccharides reduce neuronal damage, bloodretinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury. PloS one 6 (2011).
14. Xiao, J. et al. Lycium barbarum polysaccharides protect mice liver from carbon tetrachloride-induced oxidative stress and necroinflammation. J. Ethnopharmacol. 139, 462-470 (2012).
15. Xiao, J. et al. Lycium barbarum polysaccharides protect rat liver from nonalcoholic steatohepatitis-induced injury. Nutr. Diabetes. 3, e81 (2013).
16. Tipoe, G. L. et al. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). Histol. Histopathol. 24, 1161-1169 (2009).
17. Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41, 1313-1321 (2005). (Pubitemid 40770284)
18. Cheng, K. K. et al. APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab. 9, 417-427 (2009).
19. McGuinness, O. P., Ayala, J. E., Laughlin, M. R. & Wasserman, D. H. NIH experiment in centralized mouse phenotyping: the Vanderbilt experience and recommendations for evaluating glucose homeostasis in the mouse. Am. J. Physiol. Endocrinol. Metab. 297, E849-E855 (2009).
20. Krog-Mikkelsen, I. et al. The effects of L-arabinose on intestinal sucrase activity: dose-response studies in vitro and in humans. Am. J. Clin. Nutr. 94, 472-478 (2011).
21. Martin, K. R., Failla, M. L. & Smith, J. C., Jr. Beta-carotene and lutein protect HepG2 human liver cells against oxidant-induced damage. J. Nutr. 126, 2098-2106 (1996). (Pubitemid 26313586)
22. Xiao, J. et al. Tumor necrosis factor-alpha gene from mandarin fish, Siniperca chuatsi: molecular cloning, cytotoxicity analysis and expression profile. Mol. Immunol. 44, 3615-3622 (2007). (Pubitemid 46754443)
23. Bustin, S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611-622 (2009).
24. Cassiman, D. et al. Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am. J. Pathol. 155, 1831-1839 (1999).
25. Albano, E., Mottaran, E.,Occhino, G., Reale, E. & Vidali, M. Review article: role of oxidative stress in the progression of non-alcoholic steatosis. Aliment. Pharmacol. Ther. 22 Suppl 2, 71-73 (2005). (Pubitemid 41564388)
26. Zhang, Y. et al. Silibinin ameliorates steatosis and insulin resistance during nonalcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway. Int. Immunopharmacol. 17, 714-720 (2013).
27. Mahady, S. E. & George, J. Management of nonalcoholic steatohepatitis: an evidence-based approach. Clin. Liver Dis. 16, 631-645 (2012).
28. Polyzos, S. A., Kountouras, J. & Zavos, C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr. Mol. Med. 9, 299-314 (2009).
29. Utzschneider, K. M. & Kahn, S. E. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol.Metab. 91, 4753-4761 (2006). (Pubitemid 44917301)
30. Draznin, B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes 55, 2392-2397 (2006). (Pubitemid 44743640)
31. Ciaraldi, T. P., Nikoulina, S. E., Bandukwala, R. A., Carter, L. & Henry, R. R. Role of glycogen synthase kinase-3 alpha in insulin action in cultured human skeletal muscle cells. Endocrinology 148, 4393-4399 (2007). (Pubitemid 47295685)
32. Cheng, D. & Kong, H. The effect of Lycium barbarum polysaccharide on alcoholinduced oxidative stress in rats. Molecules. 16, 2542-2550 (2011).
33. Ming, M., Guanhua, L., Zhanhai, Y., Guang, C. & Xuan, Z. Effect of the Lycium barbarum polysaccharides administration on blood lipid metabolism and oxidative stress of mice fed high-fat diet in vivo. Food Chem. 113, 872-877 (2009).
34. Feldstein, A. E. et al.Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 3, 384-389 (2005). (Pubitemid 40488347)
35. Adachi, M. et al. The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. Gastroenterology. 132, 1434-1446 (2007). (Pubitemid 46627569)
36. van den Berg, R., Haenen, G. R., van den Berg, H. & Bast, A. Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br. J. Nutr. 86 Suppl 1, S121-127 (2001).
37. Wang, H. & Cho, C. H. Effect of NF-kappaB signaling on apoptosis in chronic inflammation-associated carcinogenesis. Curr. Cancer Drug Targets. 10, 593-599 (2010).
38. Sumida, Y., Niki, E., Naito, Y. & Yoshikawa, T. Involvement of free radicals and oxidative stress in NAFLD/NASH. Free Radic. Res. 47, 869-880 (2013).
39. Li, L. et al. Resveratrol modulates autophagy and NF-kappaB activity in a murine model for treating non-alcoholic fatty liver disease. Food Chem. Toxicol. 63, 166-173 (2014).
40. Moscat, J. & Diaz-Meco, M. T. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell. 137, 1001-1004 (2009).
41. Li, X. L., Zhou, A. G. & Li, X. M. Inhibition of Lycium barbarum polysaccharides and Ganoderma lucidum polysaccharides against oxidative injury induced by c-irradiation in rat liver mitochondria. Carb. Pol. 69, 172-178 (2007). (Pubitemid 46497425)
42. Wang, C. C., Chang, S. C. & Chen, B. H. Chromatographic determination of polysaccharides in Lycium barbarumLinnaeus. Food Chem. 116, 595-603 (2009).
43. Inbaraj, B. S. et al. Determination of carotenoids and their esters in fruits of Lycium barbarum Linnaeus by HPLC-DAD-APCI-MS. J. Pharm. Biomed. Anal. 47, 812-818 (2008).
44. Peng, Y. et al. Quantification of zeaxanthin dipalmitate and total carotenoids in Lycium fruits (Fructus Lycii). Plant Foods Hum. Nutr. 60, 161-164 (2005). (Pubitemid 43052210)